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CASE  REPORT
Introduction
Extraosseous osteogenic sarcoma of the somatic soft
tissue is an extremely rare type of tumor, constituting
only 1.2% of all soft tissue sarcomas.1 The first case was
reported by Wilson in 1941.2 Since then, less than 200
cases have been reported in the English literature.1–11
The tumors occur in middle-aged and elderly patients.
A previous report showed that the response of extra-
osseous osteogenic sarcoma to multimodality thera-
py is not as good as that of intraosseous osteogenic
sarcoma.4 Out of the more than 400 cases of soft tis-
sue sarcomas on file in our hospital, only 2 were extra-
osseous osteogenic sarcomas. The present study re-
views these 2 cases from all of the 102 osteogenic
sarcomas recorded at our institution during the 10-
year period from 1990 to 1999.
Case Reports
Case 1
A 68-year-old woman had noted a small mass over her
left thigh since the early 1970s, after a fall from a
stairway. In the past 8 months, the mass progressively
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enlarged and a painful sensation developed over her
left thigh, but there was no obvious trauma. She was,
therefore, taken to our clinic and admitted for further
treatment in November 1996.
On physical examination, a tender movable soft
tissue mass, about 8 cm in diameter, over the medial as-
pect of her left thigh was found. Radiography revealed
a soft tissue mass with calcification over the left thigh
(Figure 1). As the mass had grown very slowly over the
years, the initial impression was that it was a benign
lesion. Computer tomography of the lungs and whole
body bone scintigraphy showed no lung or bone
involvement. The tumor, measuring 9 × 7 × 6 cm, was
excised with a margin. Microscopically, a network of
eosinophilic, irregular and glassy osteoid structures
interposed with pleomorphic-nuclei spindle cells were
seen (Figure 2). The diagnosis of extraosseous osteo-
genic sarcoma was made. Fortunately, the cut mar-
gins and skin were free of tumor cells.
As the margin of the tumor excision was not wide
enough, postoperative radiotherapy with 60 Gy in 30
fractions was given. However, the patient refused any
kind of chemotherapy. After 90 months of follow-up,
she was alive without evidence of local recurrence or
distant metastasis.
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Case 2
A 69-year-old woman had undergone modified radical
mastectomy for breast adenocarcinoma in 1974. After
the operation, she was continuously free of the disease.
However, she found a small nodule over her left thigh,
just below the inguinal area, in March 1995, 3 months
prior to presentation. The soft tissue mass grew rapidly
and became painful. A plain radiograph and magnetic
Figure 1. (A) X-ray shows a soft tissue mass with calcification over
the left thigh (arrow). (B) Computed tomography scan shows a
soft tissue mass with calcification arising from the soft tissue,
without bony involvement (arrow).
Figure 2. Case 1: a network of eosinophilic irregular and glassy
osteoid structures interposed with pleomorphic-nuclei spindle
cells.
resonance imaging (MRI) of the left proximal femur
showed a calcified soft tissue mass over the upper
medial thigh without a skeletal lesion (Figure 3). As
the mass grew rapidly and MRI showed central necrosis,
malignancy was highly suspected. Wide excision was
performed. The neurovascular bundle lateral to the
mass was well protected and preserved. Histopathol-
ogic examination revealed extraosseous osteogenic
sarcoma with muscle involvement (Figure 4). The cut
margins were free of tumor cells. Adjuvant chemo-
therapy with cisplatin and doxorubicin was admin-
istered postoperatively. No local recurrence or dis-
tant metastasis was noted from a postoperative
105-month follow-up.
Discussion
Extraosseous osteogenic sarcoma arising from soft
tissue constitutes 1.2% of all soft tissue sarcomas.1 At
the Rosewell Park Memorial Institute, 4.6% of all
osteogenic sarcomas were of soft tissue origin. A
similar incidence has been reported by Allan and
Soule,1 and Wurlitzer et al.3
At the Memorial Sloan-Kettering Cancer Center, a
review of 48 cases of extraosseous osteogenic sarcoma
during 1950–1983 showed the median age at diagnosis
to be 51 years (range, 6–80 years).4 The most common
primary sites were the thighs and buttocks (26 cases,
54.2%). Spotty areas of calcification were seen in pre-
operative radiographs of the tumor in about half of the
cases. Forty-one (91.1%) of the 45 patients who had
been followed for more than 1 year developed local
recurrence and/or distant metastasis.
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While osteogenic sarcoma of bone occurs most
frequently in children and adolescents, patients with
extraosseous osteogenic sarcomas are usually older
than 40 years. A recent review of the literature placed
the mean age of patients with extraosseous osteogenic
sarcoma at 53 years.5 Our 2 patients were older than
Figure 4. The tumor is composed of osteoid and atypical osteo-
blasts with muscle involvement. It is a high-grade tumor similar
to conventional osteosarcoma.
Figure 3. (A) X-ray shows a soft tissue mass with calcification over
the left upper medial thigh (arrow). (B, C) Magnetic resonance
imaging shows a soft tissue mass over the left upper medial thigh
without skeletal lesion (arrows).
53 years of age (68 and 69 years). The common mode
of presentation is swelling of insidious onset, with
associated pain in approximately 1-third of patients.
Frequently, the tumor grows to a large size before the
patient seeks medical advice. The mean duration of
symptoms before diagnosis was 3 months.4 The dura-
tion of symptoms before diagnosis in our 2 patients
were 8 and 3 months. Previous radiation therapy is a
well-known predisposing factor for the development
of both soft tissue and bone sarcoma.6 The role of
trauma in the incidence of extraosseous osteogenic sar-
coma is controversial. Several authors have suggested
that trauma can be an important etiologic factor in the
development of these neoplasms.7 One of our 2 patients
had a history of trauma.
Radiographic examination of the soft tissue is
essential to rule out any continuity of the tumor with
bone. If adjacent bone shows radiologic changes of
involvement by the tumor, it is most likely to be
sarcoma originating from the bone rather than from
the soft tissue. A soft tissue mass with spotty calcifica-
tion without adjacent bone involvement is one of the
classic radiographic appearances of this tumor, which
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The single most important criterion for diagnosis of
this tumor is the presence of malignant osteoid.8 Indeed,
a variable amount of fibroblastic and chondroblastic
components may also be present. In limited biopsy
material, in the absence of malignant osteoid and
malignant chondrocytes, extraosseous osteogenic sar-
coma may resemble malignant giant cell tumor or
malignant fibrous histiocytoma of soft tissue. There-
fore, specific histologic identification should be done
only after generous sampling of the neoplasm. In ad-
dition, this tumor should be differentiated from
myositis ossificans. The presence of a wide spectrum
of malignant neoplastic elements and conspicuous
absence of inflammatory cells and areas of hemor-
rhagic necrosis help to rule out myositis ossificans.
Wide local excision, with at least a 5-cm margin of
normal tissue, should be the treatment of choice. If
this is not feasible due to the anatomic location of the
tumor, amputation should be recommended.9 Due to
the high tendency of extraosseous osteogenic sarcoma
to recur after resection, simple excision or enucleation
of the tumor should not be considered. Since recur-
rence occurs mostly within 2 years after treatment, ad-
juvant chemotherapy and radiotherapy might be of
benefit. However, a review of 48 cases of extraosseous
osteogenic sarcoma and 39 trials of chemotherapy
agents or combinations, including 16 combinations
containing doxorubicin, showed that no patients had
a major response.4 The average 5-year survival rates in
5 previous studies range from 15% to 25%.1,3,5,6,10
Around 80% of patients died within 2–3 years. These
survival rates are comparable with those of “classic”
type osteogenic sarcoma and poorly differentiated
soft tissue sarcoma. Fortunately, both of our patients
(1 received wide excision and adjuvant chemotherapy,
the other received marginal excision and postoperative
radiotherapy) continue to be disease-free. The reasons
for these encouraging results are unknown, but we
should not underestimate the severity of the disease.
Careful preoperative evaluation and multimodal
treatment are essential in the management of patients
with extraosseous osteogenic sarcoma.
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